Interventions: Salmeterol xinafoate 42 mcg via metered dose inhaler twice daily or oral zafirlukast 20 mg twice daily. Main Outcome Measures: Pulmonary function, asthma symptoms, supplemental ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate ... 500µg twice daily from a Diskus™ inhaler for a 4-week run-in period, dependent ...
The transition occurred in nearly 75% of this study population, and researchers found that a prescription for a non-fluticasone-salmeterol dry-powder inhaler in this group was reported in 14.2% of ...
Last year saw a key development in the US respiratory diseases market when Mylan finally launched its generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback